HLA antibody testing: a tool to facilitate not to prevent organ transplantation

被引：16

作者：

Claas, Frans H. J. ^{[1
]}

机构：

[1] Leiden Univ, Med Ctr, Dept Immunohaematol & Blood Transfus, NL-2300 RC Leiden, Netherlands

来源：

INTERNATIONAL JOURNAL OF IMMUNOGENETICS | 2008年 / 35卷 / 4-5期

关键词：

D O I：

10.1111/j.1744-313X.2008.00800.x

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

The introduction of very sensitive HLA antibody screening assays has destroyed the old dogma that pre-existence of donor specific HLA antibodies in the patient is a contra-indication for transplantation. The challenge is now to reach consensus on the parameters which predict the clinical relevance of donor specific HLA antibodies. Antibody screening assays should not only be used to prevent transplantation of patients with donor specific antibodies but also to facilitate transplantation of highly sensitized patients, both by defining acceptable HLA mismatches and non-detrimental donor specific HLA antibodies.

引用

页码：275 / 277

页数：3

共 11 条

[1] The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: Short waiting time and excellent graft outcome [J].

Claas, FHJ ;

Witvliet, MD ;

Duquesnoy, RJ ;

Persijn, GG ;

Doxiadis, IIN .

TRANSPLANTATION, 2004, 78 (02) :190-193

[2] The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens [J].

Dankers, MKA ;

Witvliet, MD ;

Roelen, DL ;

De Lange, P ;

Korfage, N ;

Persijn, GG ;

Duquesnoy, R ;

Doxiadis, IIN ;

Claas, FHJ .

TRANSPLANTATION, 2004, 77 (08) :1236-1239

[3] Extending options for highly sensitized patients to receive a suitable kidney graft [J].

Doxiadis, IIN ;

Duquesnoy, RJ ;

Claas, FHJ .

CURRENT OPINION IN IMMUNOLOGY, 2005, 17 (05) :536-540

[4] Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes [J].

Duquesnoy, Rene J. ;

Awadalla, Yehia ;

Lomago, Jon ;

Jelinek, Larry ;

Howe, Judy ;

Zern, Dwayne ;

Hunter, Betty ;

Martell, Joan ;

Girnita, Alin ;

Zeevi, Adriana .

TRANSPLANT IMMUNOLOGY, 2008, 18 (04) :352-360

[5] A structurally based approach to determine HLA compatibility at the humoral immune level [J].

Duquesnoy, Rene J. .

HUMAN IMMUNOLOGY, 2006, 67 (11) :847-862

[6]

El-Awar Nadim, 2007, Clin Transpl, P175

[7] Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: Contraindication vs. risk [J].

Gebel, HM ;

Bray, RA ;

Nickerson, P .

AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (12) :1488-1500

[8] THE ROLE OF IGA ANTI-HLA CLASS-I ANTIBODIES IN KIDNEY-TRANSPLANT SURVIVAL [J].

KOKA, P ;

CHIA, D ;

TERASAKI, PI ;

CHAN, H ;

CHIA, J ;

OZAWA, M ;

LIM, E .

TRANSPLANTATION, 1993, 56 (01) :207-211

[9] Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study [J].

Mao, Q. ;

Terasaki, P. I. ;

Cai, J. ;

Briley, K. ;

Catrou, P. ;

Haisch, C. ;

Rebellato, L. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (04) :864-871

[10] SIGNIFICANCE OF POSITIVE CROSSMATCH TEST IN KIDNEY TRANSPLANTATION [J].

PATEL, R ;

TERASAKI, PI .

NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (14) :735-&

← 1 2 →